There are several CMA substrates linked to PD development, including PARK7, leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2), and ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1) [8]. Here, LRRK2 is linked to Parkinson disease.